BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35440212)

  • 1. Low pre-pregnant body mass index is a risk factor for the decrease of postpartum bone mineral density in systemic lupus erythematosus patients received glucocorticoid therapy.
    Ishida T; Yuri H; Nakamura E; Isoda K; Wada Y; Kotani T; Takeuchi T
    Lupus; 2022 Jun; 31(7):848-854. PubMed ID: 35440212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.
    Jacobs J; Korswagen LA; Schilder AM; van Tuyl LH; Dijkmans BA; Lems WF; Voskuyl AE; Bultink IE
    Osteoporos Int; 2013 Jun; 24(6):1827-33. PubMed ID: 23052940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus.
    Mok CC; Wong SN; Ma KM
    Rheumatology (Oxford); 2012 Mar; 51(3):468-75. PubMed ID: 22096013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.
    Ishida T; Yoshida S; Kimura Y; Fujiki Y; Kotani T; Takeuchi T; Makino S; Arawaka S
    Lupus; 2018 Sep; 27(10):1636-1643. PubMed ID: 29954283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls.
    Gilboe IM; Kvien TK; Haugeberg G; Husby G
    Ann Rheum Dis; 2000 Feb; 59(2):110-5. PubMed ID: 10666165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
    Sánchez-Guerrero J; Fragoso-Loyo HE; Neuwelt CM; Wallace DJ; Ginzler EM; Sherrer YR; McIlwain HH; Freeman PG; Aranow C; Petri MA; Deodhar AA; Blanton E; Manzi S; Kavanaugh A; Lisse JR; Ramsey-Goldman R; McKay JD; Kivitz AJ; Mease PJ; Winkler AE; Kahl LE; Lee AH; Furie RA; Strand CV; Lou L; Ahmed M; Quarles B; Schwartz KE
    J Rheumatol; 2008 Aug; 35(8):1567-75. PubMed ID: 18634158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Kipen Y; Briganti E; Strauss B; Will R; Littlejohn G; Morand E
    J Rheumatol; 1999 Feb; 26(2):310-7. PubMed ID: 9972964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT.
    Tang XL; Qin L; Kwok AW; Zhu TY; Kun EW; Hung VW; Griffith JF; Leung PC; Li EK; Tam LS
    Osteoporos Int; 2013 Jun; 24(6):1817-26. PubMed ID: 23104200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Uaratanawong S; Deesomchok U; Hiransuttikul N; Uaratanawong S
    J Med Assoc Thai; 2004 Nov; 87(11):1374-9. PubMed ID: 15825716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus.
    Mendoza-Pinto C; García-Carrasco M; Sandoval-Cruz H; Escárcega RO; Jiménez-Hernández M; Etchegaray-Morales I; Soto-Vega E; Muñoz-Guarneros M; López-Colombo A; Delezé-Hinojosa M; Cervera R
    Clin Rheumatol; 2009 Jan; 28(1):65-70. PubMed ID: 18670734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine.
    Jardinet D; Lefèbvre C; Depresseux G; Lambert M; Devogelaer JP; Houssiau FA
    Rheumatology (Oxford); 2000 Apr; 39(4):389-92. PubMed ID: 10817771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of long-term low dose prednisone on bone mineral density in patients with systemic lupus erythematosus].
    Wang G; Li XP; Li XM; Wang GS; Tao JH; Ma Y
    Zhonghua Nei Ke Za Zhi; 2017 Mar; 56(3):179-183. PubMed ID: 28253597
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study.
    Mok CC; Ying SKY; To CH; Ma KM
    Bone; 2008 Aug; 43(2):327-331. PubMed ID: 18515206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BONE MINERAL DENSITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS--OUR RESULTS].
    Gracanin AG; Marković I; Loncarević J; Golob M; Morović-Vergles J
    Reumatizam; 2015; 62(2):16-21. PubMed ID: 26882799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.
    Sinigaglia L; Varenna M; Binelli L; Zucchi F; Ghiringhella D; Gallazzi M; Limonta M; Zeni S; Fantini F
    J Rheumatol; 1999 Jun; 26(6):1280-4. PubMed ID: 10381043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Analysis of Longitudinal Changes in Bone Mineral Density in Women with Systemic Lupus Erythematosus.
    Mendoza-Pinto C; García-Carrasco M; Juárez-Melchor D; Munguía-Realpozo P; Etchegaray-Morales I; Santiago-Martín N; Ayón-Aguilar J; Méndez-Martínez S
    Calcif Tissue Int; 2021 Oct; 109(4):363-371. PubMed ID: 33864471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure.
    Boone JB; Wheless L; Camai A; Tanner SB; Barnado A
    Lupus; 2021 Mar; 30(3):403-411. PubMed ID: 33307984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical thinning and progressive cortical porosity in female patients with systemic lupus erythematosus on long-term glucocorticoids: a 2-year case-control study.
    Zhu TY; Griffith JF; Qin L; Hung VW; Fong TN; Au SK; Tang XL; Kun EW; Kwok AW; Leung PC; Li EK; Tam LS
    Osteoporos Int; 2015 Jun; 26(6):1759-71. PubMed ID: 25736166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus.
    Zhu L; Zhang J; Wang J; Lv X; Pu D; Wang Y; Men Q; He L
    Lupus; 2021 Jun; 30(7):1116-1123. PubMed ID: 33832361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.